Safe PAD Trial—Breakdown of the Data | SCAI
Jul 15th 2021 | News & Clinical Trials

Safe PAD Trial—Breakdown of the Data

Pulmonary Embolism

Evaluating whether drug-coated devices (DCDs) used for femoropopliteal artery revascularization are non-inferior to non-drug-coated devices (NDCDs) in respect to all-cause mortality; assessing the potential for unmeasured confounding; and investigating whether there is consistent safety of DCDs across different patient profiles.